4Dunaif A.Hyperandrogenic anovulation (PCOS):a uniquic disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.Am J Med,1995,98 (Suppl):33-39.
5The Rotterdam ESHRE/ASRM-Sponsored PCOS Con sensus Workshop Group.Revised 2003 consensus on disgnostic criteria and long-term health risks related to polyeystic ovary syndrome.Fertil Steril,2004,81 (1):19-25.
6Kiddy DS,Hamilton-Fairley D,Bush A,et al.Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovarian syndrome.Clin Endocrinol (Oxf),1992,36(1):105-111.
7Nestler JE,Powers LP,Matt DW,et al.A direct effect of hyperinsulinemia on serum sex hormone binding glob ulin levels in obese women with the polycystic ovary syn drome.J Clin Endocrinol Metab,1991,72:83-89.
8Carmina E.Dignosis of polycystic ovary syndrome:fromNIH criteria to ESHRE ASRM guidelines[].Minerva Ginecologica.2004
9Moghetti P,Castello R,Negri C,et a1.Metformin effetson clinical features,endocrine and metabolic profiles,and insulin sensitivity in polycystic ovary syndrome:arandomized,double blind,placebo controlled 6 monthtrial,followed by open,long term clinical evalution[].Journal of Clinical Endocrinology and Metabolism.2000
10Kaltsas GA,Korbonits M,isidori AM,et a1.How com-mon are polycystic ovaries and the polycystic ovariansyndrome in women with Cushing’s syndrome[].CinEndocrinol(Oxf).2000
1Qu ZY, Shi YH, Zhao DN, et al. Effect of obesity on nonalcoholicfatty liver disease in Chinese women with polycystic ovary syndrome[J]. Zhonghua Yi Xue Za Zhi, 2010,90(29): 2036- 2039.
2Hardiman P,Pillag OS,Atioma W. Polycytic ovarg syndrome and endometrial carcinma[J].{H}LANCET,2003,(9389):1082.
3Azziz R. Controversy in clinical endocrinology:diagnosis of polycystic ovarian syndrome:the Rotterdam criteria are premature[J].The Journal of Clinical Endocrinology and Metabolism,2012,(3):781-785.
